JNJ Press releases
News
Partner news
Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy
Read full storyJNJ Press releases
Johnson & Johnson Innovation and Janssen Award U.S. $1.5 Million in Grants for World Without Disease QuickFire Challenge
Read full storyPartner news
ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop® Near Vision Inlay
Read full storyPartner news
Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients
Read full storyJNJ Press releases
“Pitch Your Microbes” Competition at the European Microbiome Congress
Read full storyPartner news
BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders
Read full storyJNJ Press releases
JLINX Science Meets Business Symposium
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces New Collaboration with TMC
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces New Collaboration with Texas Medical Center to Spur Development of Breakthrough Medical Device Technologies
Read full storyJNJ Press releases
Johnson & Johnson, Texas Medical Center join forces to develop medical devices in Houston
Read full storyJNJ Press releases
J&J to create new Texas center to develop ‘breakthrough’ med tech
Read full storyPartner news
TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc.
Read full storyPartner news
CVRx® Secures $113 Million in New Financing
Read full storyPartner news